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Louis-Lariboisière-Fernand-Widal, Paris, FranceAbstractMolecular methods are crucial for mucormycosis diagnosis
because cultures are frequently negative, even if microscopy
suggests the presence of hyphae in tissues. We assessed PCR/
electrospray-ionization mass spectrometry (PCR/ESI-MS) for
Mucorales identiﬁcation in 19 unﬁxed tissue samples from 13
patients with proven or probable mucormycosis and compared
the results with culture, quantitative real-time PCR, 16S–23S
rRNA gene internal transcribed spacer region (ITS PCR) and
18S PCR sequencing. Concordance with culture identiﬁcation
to both genus and species levels was higher for PCR/ESI-MS
than for the other techniques. Thus, PCR/ESI-MS is suitable
for Mucorales identiﬁcation, within 6 hours, for tissue
samples for which microscopy results suggest the presence of
hyphae.
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workIntroductionMucormycosis is an invasive fungal disease affecting severely
immunocompromised patients, patients with uncontrolled dia-
betes and patients with severe trauma contaminated with soil [1].
The rapid diagnosis of mucormycosis is essential because mor-
tality is high but can be decreased by rapid treatment initiation,
including surgery, when possible [2]. Microbiologic diagnosis is
based principally on microscopy and the culture of a fresh spec-
imen, and on histologic analysis of formalin-ﬁxed parafﬁn-
embedded biopsy specimens. Culture results are often negative
[1], but when positive, the isolate can be used for species identi-
ﬁcation and antifungal susceptibility testing [3]. Various nucleic
acid–based identiﬁcation methods for Mucorales identiﬁcation
have been developed, including quantitative real-time PCR (qPCR)
for a portion of the 18S ribosomal RNA gene (18S rRNA gene)
[4], PCR ampliﬁcation and sequencing of 18S–28S rRNA gene
internal transcribed spacer region (ITS PCR) [5] and sequencing of
a region of the 18S rRNA gene (18S PCR) [6–8].
PCR coupled with electrospray-ionization mass spectrom-
etry (PCR/ESI-MS) is a promising method [9,10] never before
evaluated speciﬁcally for Mucorales detection and identiﬁcation
on tissues. PCR/ESI-MS involves 16 single-plex PCR assays on
standardized DNA extracts, with broad-range primers targeting
nuclear or mitochondrial genes; rapid determination of the
molecular weight and base composition of the amplicon by
electrospray-ionization mass spectrometry; and comparison
with a speciﬁc database generated by the manufacturer. We
compared the efﬁcacy of PCR/ESI-MS with three other pub-
lished molecular methods [4–6] for identiﬁcation purposes on
unﬁxed tissue biopsy specimens containing Mucorales hyphae
visible upon direct or pathologic examination.Diseases. Published by Elsevier Ltd. All rights reserved
CMI Alanio et al. Molecular identiﬁcation of Mucorales 594.e2Materials and methodsWe collected 19 tissue biopsy specimens from 13 patients with
proven mucormycosis according to the European Organisation
for Research and Treatment of Cancer/Invasive Fungal In-
fections Cooperative Group and the National Institute of Al-
lergy and Infectious Diseases Mycoses Study Group (EORTC/
MSG) criteria [11]. Twelve specimens (all culture positive) from
seven patients were obtained from patients included in the
AMBIZYGO trial (NCT00467883; Lanternier et al., personal
communication) and were frozen at −80°C (Table 1). Seven
consecutive biopsy specimens from six patients with Mucorales
hyphae visible on microscopy were collected prospectively over
a 2-year period at Saint-Louis Hospital, Paris, France (Table 1).
Each specimen was split in two. One part was placed on Sab-
ouraud dextrose agar. For culture-positive specimens, one
colony was subcultured and sent to the French National
Reference Center for Invasive Mycoses and Antifungals, where
species identiﬁcation was performed by a polyphasic approach,
as described elsewhere [12,13]. The other part of the sample
was frozen at −80°C for molecular studies. It was then thawed,
and 1 g of tissue was cut off with a sterile scalpel and used for
DNA extraction on the PLEX-ID platform (Abbott Molecular).
DNA extracts were subjected to PCR/ESI-MS, qPCR assays, and
ITS PCR and 18S rRNA gene sequencing (Table 2).
PCR/ESI-MS analysis was performed with the Fungal


















4 Skin (left arm) Lichtheimia corymbifera
5 Skin (left forearm) Lichtheimia corymbifera
6 Skin (left thigh) Lichtheimia corymbifera
4 7 Lichtheimia ramosa Kidney Lichtheimia corymbifera
5 8 Rhizopus arrhizus Mandibular bone Rhizopus arrhizus
9 Gum (left) Rhizopus arrhizus
10 Gum (right) Rhizopus arrhizus
6 11 Cunninghamella
spp.
Skin (thigh) Ampliﬁcation failure
7 12 Rhizopus arrhizus Sinus Rhizopus arrhizus
8 13 Lichtheimia ramosa Skin (thigh) Lichtheimia ramosa
9 14 Mucor circinelloides Skin (hand) Mucor circinelloides
10 15 Rhizopus arrhizus Sinus Rhizopus arrhizus
11 16 Negative Liver Lichtheimia corymbifera
17 Negative Liver Lichtheimia corymbifera
12 18 Negative Lung Lichtheimia corymbifera
13 19 Negative Skin (face) Rhizopus microsporus
18S PCR, 18S rRNA gene PCR identiﬁcation; ITS PCR, 16S–23S rRNA gene internal transcri
quantitative real-time PCR.
aMicroscopic examination demonstrated nonseptate hyphae suggestive of Mucorales in all sam
from patients enrolled in the AMBIZYGO trial. Samples 13 to 21 were from patients manag
bQuantiﬁcation cycle: the higher the value, the lower the fungal DNA content.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Inmitochondrial cytochrome b gene [9]. PCR was performed
after DNA extraction in six wells for broad fungal identiﬁ-
cation and in 10 wells for speciﬁc identiﬁcation. Amplicon
mass was analysed with a PLEX-ID analyser (Abbott Molec-
ular). Base composition was determined and compared with
the PLEX-ID v2.0 Fungal Spectrum database. Results were
considered validated if Q-score (conﬁdence) was 0.85 and
level (quantity) was 3. The three qPCR assays for Mucorales
identiﬁcation were performed as described elsewhere [4].
qPCR was a reliable method for fungal load determination,
providing a quantiﬁcation cycle (Cq) value. Species-level
identiﬁcation was intrinsically impossible in these qPCR as-
says. The transcribed spacer region (ITS) was ampliﬁed with
ITS1– ITS2, ITS5– ITS2 and ITS3– ITS4 primers, together with
part of the 18S rRNA gene (18S PCR) [6], and the
amplicons were then subjected to sequencing. The species
with the best score in the Mycobank database was consid-
ered [14].
We used Cohen’s kappa coefﬁcient to assess the consistency
between the four methods and culture identiﬁcation [15,16].
Sensitivity/speciﬁcity calculations were not possible because
only microscopy-positive biopsy specimens were studied.ResultsMucorales identiﬁcation with PCR/ESI-MS, qPCR, ITS PCR







Ampliﬁcation failure Saksenaea spp. Apophysomyces elegans
Lichtheimia spp. (29.2) Lichtheimia ramosa Lichtheimia ramosa
Lichtheimia spp. (34.6) Lichtheimia corymbifera Ampliﬁcation failure
Lichtheimia spp. (35.6) Ampliﬁcation failure Ampliﬁcation failure
Lichtheimia spp. (39) Ampliﬁcation failure Ampliﬁcation failure
Lichtheimia spp. (38.4) Ampliﬁcation failure Ampliﬁcation failure
Lichtheimia spp. (30.3) Lichtheimia corymbifera Lichtheimia corymbifera
Rhizopus spp./Mucor spp. (33) Ampliﬁcation failure Ampliﬁcation failure
Rhizopus spp./Mucor spp.
(15.7)
Rhizopus arrhizus Rhizopus spp.
Rhizopus spp./Mucor spp. (31) Rhizopus arrhizus Rhizopus spp.
Ampliﬁcation failure Ampliﬁcation failure Ampliﬁcation failure
Rhizopus spp./Mucor spp.
(32.7)
Rhizopus arrhizus Rhizopus spp.
Lichtheimia spp. (34.6) Lichtheimia ramosa Lichtheimia spp.
Rhizopus spp./Mucor spp. (42) Ampliﬁcation failure Ampliﬁcation failure
Rhizopus spp./Mucor spp.
(26.1)
Rhizopus arrhizus Rhizopus spp.
Lichtheimia spp. (34.3) Lichtheimia corymbifera Lichtheimia corymbifera
Lichtheimia spp. (32) Lichtheimia corymbifera Lichtheimia corymbifera
Lichtheimia spp. (37.5) Ampliﬁcation failure Ampliﬁcation failure
Rhizopus spp./Mucor spp.
(36.4)
Ampliﬁcation failure Ampliﬁcation failure
bed spacer PCR; PCR/ESI-MS, PCR/electrospray-ionization mass spectrometry; qPCR,
ples except samples11 (negative) and sample 12 (not available). Samples 1 to 12 were
ed at Saint-Louis Hospital, Paris, France.
fectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 594.e1–594.e5
TABLE 2. Characteristics of identiﬁcation assays and Cohen kappa statistics measured in agreement with culture identiﬁcation in
the validation study
Characteristic PCR/ESI-MS qPCR ITS PCR 18S PCR




10× buffer for Taq Gold
(Applied Biosystems)
10× buffer for Taq Gold
(Applied Biosystems)
No. of assays 16 3 3 1
PCR volume 75 μL 20 μL 50 μL 50 μL
DNA volume 30 μL 9 μL 9 μL 9 μL
MgCl2 concentration NA NA 2 mM 2.5 mM
dNTP concentration NA NA 200 μM 100 μM
Primer concentration NA 1 μM 0.2 μM 1 μM
PCR program
 10 min at 95°C
 (30 s at 95°C,
30 s at 48°C,
30 s at 72°C)
8 cycles
 (15 s at 95°C,
20 s at 56°C,
20 s at 72°C)
37 cycles
 2 min at 72°C
 10 min 95°C
 (15 s at 95°C and
1 min at 60°C)
50 cycles
 7 min at 95°C
 (30 s at 95°C,
30 s at 55°C,
1 min at 72°C)
40 cycles
 10 min at 72°C
 5 min at 95°C
 (30 s at 95°C, 30 s at
50°C, 1 min at 72°C)
40 cycles
 5 min at 72°C
Platform MasterCycler
Pro S (Eppendorf)









0.80 0.76 0.49 0.37
Species-level
identiﬁcation
0.72 /a 0.14 No identiﬁcationb
18S PCR, 18S rRNA gene PCR identiﬁcation; ITS PCR, 18S–28S rRNA gene internal transcribed spacer PCR; PCR/ESI-MS, PCR/electrospray-ionization mass spectrometry; qPCR,
quantitative real-time PCR.
NA: not available
aSpecies-level identiﬁcation was intrinsically impossible with qPCR.
bNo identiﬁcation at the species level was possible using 18S PCR.
594.e3 Clinical Microbiology and Infection, Volume 21 Number 6, June 2015 CMIidentiﬁcation for 15 culture-positive biopsy specimens:
genus-level identiﬁcation was achieved for 13/15, 13/15, 9/15
and 7/12 specimens, respectively; species-level identiﬁcation
was achieved for 12/15, 0/15, 6/15 and 0/15 specimens,
respectively (Table 1). Species-level identiﬁcation by PCR/
ESI-MS was possible in specimens with low fungal DNA
loads (Cq > 39). In contrast, detection by ITS PCR and 18S
PCR was unsuccessful for Cq > 34.6 and Cq > 34.3,
respectively (Table 1). The kappa coefﬁcient with respect to
culture methods was higher for PCR/ESI-MS than for the
other methods for identiﬁcation to the genus (0.80) and
species (0.72) levels (Table 2). Discrepancies between PCR/
ESI-MS and culture were observed for the following: (a)
Saksenaea vasiformis (sample 1), misidentiﬁed as Apophyso-
myces elegans; (b) Lichtheimia ramosa (sample 7), misidentiﬁed
as Lichtheimia corymbifera but well identiﬁed in sample 13; and
(c) Cunninghamella spp. (sample 11), neither detected nor
identiﬁed (Table 1).
In the four culture-negative biopsy specimens, species-level
identiﬁcation by PCR/ESI-MS was possible; these identiﬁca-
tions were consistent with qPCR ﬁndings for identiﬁcation to
the genus level (Table 1) and with ITS PCR and 18S PCR
ﬁndings for identiﬁcations to the species level in two of four
samples.Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectDiscussionThe microbiologic diagnosis of mucormycosis is subject to several
limitations, including an inability to obtain a positive culture, an
absence of reference standard molecular techniques and confu-
sion with other mold infections, necessitating expert laboratory
intervention for accurate diagnosis. This study made use of 19
biopsy specimens from13 patients—a large number given the low
but increasing incidence of mucormycosis in France [17]. Poly-
phasic identiﬁcation of the Mucorales isolates [12,13] was per-
formed for all culture-positive cases, in contrast to previous
studies [5–8,18]. We also focused on unﬁxed tissues, the key to
optimizing molecular detection and identiﬁcation [19].
PCR/ESI-MS identiﬁed Mucorales to species level more
effectively than the other molecular methods tested, providing
results within 6 hours. The limitations of PCR/ESI-MS for
identifying rare species, such as Cunninghamella spp. or Sakse-
naea vasiformis, could be overcome by improving the PCR/ESI-
MS database.
The identiﬁcation of Mucorales species can directly affect
epidemiologic studies and treatment strategies, given the dif-
ferences in antifungal drug susceptibility between species [3].
PCR/ESI-MS is suitable for rapid identiﬁcation but is currentlyious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 594.e1–594.e5
CMI Alanio et al. Molecular identiﬁcation of Mucorales 594.e4costly (US$150 to $200 per test) and has only limited
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